Loading organizations...
Key people at TIO Bioventures.
TIO Bioventures was founded in 2018 by Tak Wah Mak (Co-founder and Managing Director) and Shane Burgess (Co-founder and Managing Director, Chief Executive Officer).
TIO Bioventures operates as a venture creation firm, conceiving, funding, and advancing innovative biotechnology companies. It identifies therapeutic areas like oncology and immunology, building enterprises dedicated to novel anti-cancer therapies. Their model leverages a broad network of scientific and entrepreneurial talent, fostering ventures from concept to early development.
Co-founded in 2019 by Shane Burgess and Dr. Tak Wah Mak, the firm was established to accelerate biotherapeutic development. Burgess brings entrepreneurial and management expertise; Dr. Mak, a distinguished T cell biology pioneer, discovered the TCR. Their collaboration combines deep scientific insight and an engaged network, translating breakthroughs into clinical solutions.
The firm primarily serves the biotechnology companies it establishes, providing foundational support and strategic oversight for their therapeutic pipelines. TIO Bioventures' long-term vision is to systematically build a portfolio of successful biotech entities. Its mission delivers transformative anti-cancer therapies, turning scientific discoveries into medical progress via disciplined company formation.
TIO Bioventures was founded in 2018 by Tak Wah Mak (Co-founder and Managing Director) and Shane Burgess (Co-founder and Managing Director, Chief Executive Officer).
Key people at TIO Bioventures.
